Evidence map›Paper›PMID 38817950›Full record

ArticleResearch and practice in thrombosis and haemostasis2024

An epidemiologic study comparing cancer- and noncancer-associated venous thromboembolism in a racially diverse Southeastern United States county.

Andrew M Peseski, Sargam Kapoor, Maragatha Kuchibhatla, Alys Adamski, Karon Abe, Michele G Beckman, Nimia L Reyes, Lisa C Richardson, Ibrahim Saber, Ryan Schulteis and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Research and practice in thrombosis and haemostasis, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Andrew M PeseskiDivision of Hematology, Department of Medicine, Duke University, Durham, North Carolina, USA.
Sargam KapoorDivision of Hematology, Department of Medicine, Duke University, Durham, North Carolina, USA.
Maragatha KuchibhatlaDepartment of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina, USA.
Alys AdamskiDivision of Blood Disorders and Public Health Genomics, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Karon AbeDivision of Blood Disorders and Public Health Genomics, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Michele G BeckmanDivision of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Nimia L ReyesDivision of Blood Disorders and Public Health Genomics, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Lisa C RichardsonDivision of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Ibrahim SaberAbbVie Inc, North Chicago, Illinois, USA.
Ryan SchulteisDepartment of Medicine, Duke University, Durham, North Carolina, USA.
Bhavana Pendurthi SinghDivision of Hematology Oncology, Lehigh Valley Hospital Pocono, East Stroudsburg, Pennsylvania, USA.
Andrea SitlingerDivision of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, North Carolina, USA.
Elizabeth H ThamesDivision of Hematology, Department of Medicine, Duke University, Durham, North Carolina, USA.
Thomas L OrtelDivision of Hematology, Department of Medicine, Duke University, Durham, North Carolina, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Cancer-associated venous thromboembolism (CA-VTE) represents a major cause of morbidity and mortality in patients with cancer. Despite poor outcomes, there is an ongoing knowledge gap in epidemiologic data related to this association. Objectives: To compare venous thromboembolism (VTE) characteristics, risk factors, and outcomes between patients with and without active cancer in a racially diverse population. Methods: Our surveillance project occurred at the 3 hospitals in Durham County, North Carolina, from April 2012 through March 2014. Electronic and manual methods were used to identify unique Durham County residents with VTE. Results: We identified 987 patients with VTE during the surveillance period. Of these, 189 patients had active cancer at the time of their VTE event. Patients with CA-VTE were older (median age: 69 years vs 60 years, Conclusion: Future studies may be needed to continue to evaluate local and national VTE data to improve VTE prevention strategies and CA-VTE outcomes.

Indexed as

cancerepidemiologic studyracesurveillancevenous thromboembolism

Identifiers

PMID38817950
PMCPMC11137544

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.